Contact
Please use this form to send email to PR contact of this press release:
Agappe to Begin Manufacturing of US FDA-Approved Plasma Markers for Alzheimer's Disease Detection in India
TO:
Agappe Digital
Agappe Diagnostics Ltd
+ +916282903297